STERIS plc (NYSE:STE) has been a central focus as its share price movements are scrutinized. Recently,
Mitsubishi UFJ Asset Management UK Ltd offloaded 5,000 shares, while
Steris PLC's stock experienced fluctuating market performance. Driving factors behind the performance are speculated to relate to the company's financials.
STERIS' Q1 FY2025 earnings surpassed expectations, hitting a revenue of $1.3 billion with a GAAP EPS of $1.41. Despite this, its operating margin saw a decrease.
Carderock Capital Management Inc. and
Mackenzie Financial Corp reduced their STERIS positions while
Daymark Wealth Partners LLC increased their stake. The company declared an increase in dividends, seemingly indicating positive earnings potential. Meanwhile, STERIS made extensive business moves, including the sale of its dental segment for $800 million, a deal on conditions with
HuFriedy Group, and announced layoffs as part of restructuring. Analysts have predicted
STERIS' target price at $246.00. The company also intends to shed its renal care business for $196 million and acquire Key Surgical for $850 million.
Steris Plc STE News Analytics from Wed, 24 Jun 2015 07:00:00 GMT to Sat, 19 Oct 2024 15:21:24 GMT -
Rating 7
- Innovation 3
- Information 8
- Rumor -5
